MetaCap

Stryker Financial Ratios

NYSE: SYKHealth CareMedical/Dental InstrumentsUSD

277.33+0.36 (+0.13%)

At close: Oct 9, 4:00 PM ET · Delayed 15 min

Stryker ratio analysis

Stryker earned a net margin of 12.9% in FY 2025, down from 13.2% a year earlier. Gross margin was 64.0% compared with a median of 64.1% over the prior 9 years. Return on equity reached 14.5%, meaning Stryker generated 0.14 dollars of profit for every dollar of shareholders' equity.

Debt-to-equity stood at 0.71 versus 0.66 the year before, and the current ratio was 1.89. At the end of FY 2025, SYK traded at 41.4 times earnings; across the 10 fiscal years shown, its year-end P/E ranged from 16.8 to 58.3, with a median of 40.5. Valuation ratios use the closing share price on each fiscal year-end date and diluted shares from the income statement; profitability and leverage ratios use reported annual figures. Current valuation multiples are on the statistics page.

Summary generated from market data by MetaCap's automated system. Methodology

Stryker financial ratios (annual)

Stryker annual financial ratios
RatioFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
P/E ratio (at fiscal year end)41.4546.5936.3039.6351.3358.3438.2516.8257.7827.54
Price / sales5.306.105.555.015.896.415.274.324.653.96
Price / book5.946.686.115.566.787.036.125.015.814.69
Gross margin64.0%63.9%63.7%62.8%64.1%63.1%65.1%65.7%65.7%66.3%
Operating margin19.5%16.3%19.0%15.4%15.1%15.5%18.2%18.7%18.5%19.2%
Net margin12.9%13.2%15.4%12.8%11.7%11.1%14.0%26.1%8.2%14.5%
Free cash flow margin17.1%15.4%15.3%11.0%16.0%19.4%10.4%15.0%7.7%12.6%
Return on equity (ROE)14.5%14.5%17.0%14.2%13.4%12.2%16.3%30.3%10.2%17.2%
Return on assets (ROA)6.8%7.0%7.9%6.4%5.8%4.7%6.9%13.0%4.6%8.1%
Debt / equity0.710.660.700.790.841.070.870.840.720.72
Current ratio1.891.951.581.632.201.932.512.022.292.50
Revenue growth11.2%10.2%11.1%7.8%19.2%-3.6%9.4%9.3%9.9%13.9%
EPS growth8.2%-5.9%33.7%18.4%24.0%-23.4%-41.3%248.5%-38.4%15.1%

Related